Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus

详细信息    查看全文

• 作者：Helle Linnebjerg ; Eric Chen Quin Lam ; Xin Zhang ; Mary E. Seger ; David Coutant ; Laiyi Chua ; Christoph Kapitza and Tim Heise
• 刊名：Diabetes, Obesity and Metabolism
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：19
• 期：1
• 页码：33-39
• 全文大小：701K
• ISSN：1463-1326

文摘

LY2963016 (LY IGlar) and Lantus (IGlar) are insulin glargine products manufactured by distinct processes, but with identical amino acid sequences. This study compared the duration of action of LY IGlar and IGlar in subjects with type 1 diabetes mellitus (T1DM).